[Ductal carcinoma in situ]

Area of Science:

• Oncology
• Breast Cancer Research
• Radiology

Background:

• Ductal carcinoma in situ (DCIS) is a non-invasive premalignant breast lesion.
• Often diagnosed via screening mammography, DCIS is typically treated like invasive breast cancer, involving mastectomy or breast-conserving surgery with radiotherapy.
• Current treatment approaches carry risks of physical and psychological side effects, and overtreatment is a concern as not all DCIS progresses to invasive cancer.

Purpose of the Study:

• To address the overtreatment of ductal carcinoma in situ (DCIS).
• To identify subgroups of women with DCIS for whom treatment could be safely omitted.
• To advance understanding of the natural history of DCIS and develop tools for personalized treatment strategies.

Main Methods:

• Review of diagnostic criteria for DCIS.
• Analysis of treatment outcomes for DCIS patients.
• Exploration of risk stratification models for DCIS progression.

Main Results:

• A significant proportion of DCIS cases may not require aggressive treatment.
• Variability exists in the natural progression of DCIS, indicating potential for selective non-treatment.
• Current data is insufficient to definitively identify low-risk DCIS subgroups amenable to treatment omission.

Conclusions:

• There is a critical need to differentiate DCIS subtypes to avoid overtreatment.
• Further research into the natural course of DCIS is essential for developing personalized treatment guidelines.
• Development of predictive tools is necessary to guide decisions on omitting treatment for select DCIS patients.